½ÃÀ庸°í¼­
»óǰÄÚµå
1651978

¼¼°èÀÇ ¼ö¸éÀå¾Ö ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¾÷°è ºÐ¼®(Áõ»óº°, Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°), ¿¹Ãø(2025-2034³â)

Sleep Disorders Market Size, Share, Trends, Industry Analysis Report: By Disorder, Product, End User, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é ¼ö¸éÀå¾Ö ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 665¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ÅëÂûÇÏ°í ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ºÒ¸éÁõ, ¼ö¸é ¹«È£Èí ÁõÈıº, ³ª¸£ÄÚ·¾½Ã µîÀÇ Áõ»óÀÇ À¯º´·ü Áõ°¡¿Í °Ç°­ Àü¹Ý¿¡ °ÉÄ£ ¼ö¸éÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡°¡ ¼ö¸éÀå¾Ö ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¼¼°è °í·ÉÈ­ Àα¸ Áõ°¡, ºñ¸¸ µî º´Á¸ ÁúȯÀÇ ³ôÀº ºñÀ², ¼ö¸é ºÎÁ·ÀÇ ¾Ç¿µÇâ¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ±âȸ·Î´Â ¿þ¾î·¯ºí ÀåÄ¡ ¹× °¡Á¤¿ë Áø´Ü µµ±¸¸¦ äÅÃÇÔ°ú µ¿½Ã¿¡ ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ È®´ë°¡ Æ÷ÇԵ˴ϴÙ. ºÒ¸éÁõ ÀÎÁö Çൿ Ä¡·á(CBT-I)¸¦ Æ÷ÇÔÇÑ ºñ ¾à¼ö󸮷ÎÀÇ Àüȯ°ú ¼ö¸é °ü¸®¿¡¼­ AI ÅëÇÕ°ú °°Àº ¼ö¸éÀå¾Ö ½ÃÀå µ¿ÇâÀº ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸·Î ÀÎÇØ ƯÈ÷ ÀÇ·á¿¡ ´ëÇÑ ¾×¼¼½º°¡ °³¼±µÇ°í ÀÖ´Â ½ÅÈï Áö¿ª¿¡¼­ ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ç´Â ż¼°¡ °®Ãß¾îÁö°í ÀÖ½À´Ï´Ù.

¼ö¸éÀå¾Ö ½ÃÀå : ºÐ¼® °³¿ä

ºÒ¸éÁõ ºÐ¾ß´Â ¼¼°èÀûÀ¸·Î À¯º´·üÀÌ ³ô±â ¶§¹®¿¡ ¼ö¸éÀå¾Ö ½ÃÀå¿¡¼­ ¼öÀÍ ±âÁØÀ¸·Î ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¼ö¸é ¹«È£Èí ÁõÈıºÀÇ ºÐ¾ß´Â ƯÈ÷ ºñ¸¸·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áø´Ü°ú Ä¡·áÀÇ µµÀÔÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç°º°·Î´Â Á¤È®Çϰí Á¶±â ¹ß°ßÀÇ Çʿ伺À¸·Î Áø´Ü ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÁö¸¸, Ä¡·á ºÐ¾ß´Â CPAP ¿ä¹ý, ¿þ¾î·¯ºí µð¹ÙÀ̽º, ºñ¾à¹° ¿ä¹ýÀÇ ±â¼ú Çõ½Å¿¡ ÃßÁøµÇ¾î ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³»°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º¹ÀâÇÑ ¼ö¸éÀå¾ÖÀÇ Áø´Ü°ú Ä¡·á¿¡ À־ÀÇ ¿ªÇÒÀÌ È®¸³µÇ¾î Àֱ⠶§¹®¿¡ º´¿ø ¹× ¼ö¸é°Ë»ç½Ç ºÐ¾ß°¡ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é Æí¸®ÇÑ °¡Á¤¿ë ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¡Á¤¿ë ÀÇ·á ºÐ¾ß°¡ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ¼ö¸éÀå¾Ö Áø´Ü·ü¿¡ °ßÀÎµÇ¾î ¼ö¸éÀå¾Ö ½ÃÀå Á¡À¯À²À» À̲ø°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á Á¢±Ù¼º Çâ»ó, ÀÎÁöµµ Çâ»ó ¹× Àα¸ °í·ÉÈ­·Î ÀÎÇØ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ºÐ¼® ¹æ¹ý

Á¦4Àå ¼ö¸éÀå¾Ö½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ¼ö¸éÀå¾Ö ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ¼ö¸éÀå¾ÖÀÇ Áø´Ü ¹× Ä¡·á¿¡ À־ÀÇ ¿ø°Ý ÀÇ·áÀÇ µµÀÔ Áõ°¡
      • ¿þ¾î·¯ºí ¼ö¸é ¸ð´ÏÅ͸µ µð¹ÙÀ̽ºÀÇ Áøº¸
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • °í¾×ÀÇ Ä¡·áºñ
  • PESTLE ºÐ¼®
  • ¼ö¸éÀå¾Ö½ÃÀå : ¿ëµµº° °æÇâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¼ö¸éÀå¾Ö ½ÃÀå : Áõ»óº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¹«ÁÁî ´Ù¸® ÁõÈıº
  • ³ª·çÄÚ·¾½Ã
  • ºÒ¸éÁõ
  • ¼ö¸é½Ã ¹«È£ÈíÁõÈıº

Á¦6Àå ¼¼°èÀÇ ¼ö¸éÀå¾Ö ½ÃÀå : Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • Áø´Ü
  • Ä¡·á

Á¦7Àå ¼¼°èÀÇ ¼ö¸éÀå¾Ö ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • º´¿ø,¼ö¸é ¿¬±¸½Ç
  • ÀçÅÃÄ¡·á

Á¦8Àå ¼¼°èÀÇ ¼ö¸éÀå¾Ö½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ¼ö¸éÀå¾Ö ½ÃÀåÀÇ Æò°¡ : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : Áõ»óº°(2020-2034³â)
    • ºÏ¹Ì : Á¦Ç°º°(2020-2034³â)
    • ºÏ¹Ì : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Áõ»óº°(2020-2034³â)
    • À¯·´ : Á¦Ç°º°(2020-2034³â)
    • À¯·´ : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: Áõ»óº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: Á¦Ç°º°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: ÃÖÁ¾ »ç¿ëÀÚº°(2020-2034³â)
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Áõ»óº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç°º°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Áõ»óº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç°º°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾»ç¿ëÀÚº°(2020-2034³â)
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • »ç¾÷ È®´ë ¹× ±â¾÷ Àμö ºÐ¼®
    • »ç¾÷ È®´ë
    • ±â¾÷ Àμö
  • Á¦ÈÞ,Çù¾÷,ÇÕÀÇ,°ø°³

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ResMed
  • Philips Healthcare
  • Medtronic
  • Fisher & Paykel Healthcare
  • Somnomed
  • Sleep Number Corporation
  • Invacare Corporation
  • Nihon Kohden Corporation
  • CareFusion
  • Becton Dickinson
  • Circadia
  • Inogen
  • Itamar Medical
  • ProTech Sleep Solutions
SHW 25.03.10

The sleep disorders market size is expected to reach USD 66.55 billion by 2034, according to a new study by Polaris Market Research. The report "Sleep Disorders Market Size, Share, Trends, Industry Analysis Report: By Disorder (Restless Legs Syndrome, Narcolepsy, Insomnia, and Sleep Apnea), Product, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of conditions such as insomnia, sleep apnea, and narcolepsy and the growing awareness of the importance of sleep for overall health drive the sleep disorders market demand. Other key drivers include the rising global aging population, high rates of comorbidities such as obesity, and the growing awareness about the negative impacts of poor sleep. Opportunities in the market include the expansion of telemedicine and remote patient monitoring, alongside the adoption of wearable devices and home-based diagnostic tools. Sleep disorders market trends such as the shift toward non-pharmacological treatments, including cognitive behavioral therapy for insomnia (CBT-I), and the integration of AI in sleep management further contribute to market expansion. With these advancements, the market is poised for continued growth, particularly in emerging regions where healthcare access is improving.

Sleep Disorders Market Report Highlights:

The insomnia segment, based on disorder, holds the largest share of the sleep disorders market revenue due to its high prevalence worldwide. However, the sleep apnea segment is expected to register the highest growth rate driven by increasing diagnosis and treatment adoption, particularly with the rising obesity rates.

The diagnostics segment, based on product, dominates the market due to the need for accurate and early detection, while the therapeutics segment is witnessing a higher growth rate, fueled by innovations in CPAP therapy, wearable devices, and non-pharmacological treatments.

By end user, the hospitals & sleep laboratories segment holds a larger share due to their established role in diagnosing and treating complex sleep disorders. On the other side, the home care settings segment is the fastest growing, driven by the increasing demand for convenient, at-home care solutions.

North America leads the sleep disorders market share, driven by advanced healthcare infrastructure and high rates of sleep disorder diagnosis. The market in Asia Pacific is growing the fastest, fueled by improving healthcare access, rising awareness, and an aging population.

Polaris Market Research has segmented the sleep disorders market report on the basis of disorder, product, end user, and region:

By Disorder Outlook (Revenue - USD Billion, 2020-2034)

  • Restless Legs Syndrome
  • Narcolepsy
  • Insomnia
  • Sleep Apnea

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Diagnostics
  • Therapeutics

By End User Outlook (Revenue - USD Billion, 2020-2034)

  • Hospitals & Sleep Laboratories
  • Home Care Settings

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Sleep Disorders Market Insights

  • 4.1. Sleep Disorders Market - Market Snapshot
  • 4.2. Sleep Disorders Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Adoption of Telemedicine for Sleep Disorder Diagnosis and Treatment
      • 4.2.1.2. Advancements in Wearable Sleep Monitoring Devices
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry Among Existing Firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Sleep Disorders Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Sleep Disorders Market, by Disorder

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
  • 5.3. Restless Legs Syndrome
    • 5.3.1. Global Sleep Disorders Market, by Restless Legs Syndrome, by Region, 2020-2034 (USD Billion)
  • 5.4. Narcolepsy
    • 5.4.1. Global Sleep Disorders Market, by Narcolepsy, by Region, 2020-2034 (USD Billion)
  • 5.5. Insomnia
    • 5.5.1. Global Sleep Disorders Market, by Insomnia, by Region, 2020-2034 (USD Billion)
  • 5.6. Sleep Apnea
    • 5.6.1. Global Sleep Disorders Market, by Sleep Apnea, by Region, 2020-2034 (USD Billion)

6. Global Sleep Disorders Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Diagnostics
    • 6.3.1. Global Sleep Disorders Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
  • 6.4. Therapeutics
    • 6.4.1. Global Sleep Disorders Market, by Therapeutics, by Region, 2020-2034 (USD Billion)

7. Global Sleep Disorders Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Sleep Laboratories
    • 7.3.1. Global Sleep Disorders Market, by Hospitals & Sleep Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.4. Home Care Settings
    • 7.4.1. Global Sleep Disorders Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)

8. Global Sleep Disorders Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Sleep Disorders Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Sleep Disorders Market - North America
    • 8.3.1. North America: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.3.2. North America: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.3.3. North America: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Sleep Disorders Market - US
      • 8.3.4.1. US: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Sleep Disorders Market - Canada
      • 8.3.5.1. Canada: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Sleep Disorders Market - Europe
    • 8.4.1. Europe: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Sleep Disorders Market - UK
      • 8.4.4.1. UK: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Sleep Disorders Market - France
      • 8.4.5.1. France: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Sleep Disorders Market - Germany
      • 8.4.6.1. Germany: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Sleep Disorders Market - Italy
      • 8.4.7.1. Italy: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Sleep Disorders Market - Spain
      • 8.4.8.1. Spain: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Sleep Disorders Market - Netherlands
      • 8.4.9.1. Netherlands: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Sleep Disorders Market - Russia
      • 8.4.10.1. Russia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Sleep Disorders Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Sleep Disorders Market - Asia Pacific
    • 8.5.1. Asia Pacific: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Sleep Disorders Market - China
      • 8.5.4.1. China: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Sleep Disorders Market - India
      • 8.5.5.1. India: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Sleep Disorders Market - Malaysia
      • 8.5.6.1. Malaysia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Sleep Disorders Market - Japan
      • 8.5.7.1. Japan: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Sleep Disorders Market - Indonesia
      • 8.5.8.1. Indonesia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Sleep Disorders Market - South Korea
      • 8.5.9.1. South Korea: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Sleep Disorders Market - Australia
      • 8.5.10.1. Australia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Sleep Disorders Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Sleep Disorders Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Sleep Disorders Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Sleep Disorders Market - UAE
      • 8.6.5.1. UAE: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Sleep Disorders Market - Israel
      • 8.6.6.1. Israel: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Sleep Disorders Market - South Africa
      • 8.6.7.1. South Africa: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Sleep Disorders Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Sleep Disorders Market - Latin America
    • 8.7.1. Latin America: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Sleep Disorders Market - Mexico
      • 8.7.4.1. Mexico: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Sleep Disorders Market - Brazil
      • 8.7.5.1. Brazil: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Sleep Disorders Market - Argentina
      • 8.7.6.1. Argentina: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Sleep Disorders Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. ResMed
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Philips Healthcare
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Medtronic
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fisher & Paykel Healthcare
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Somnomed
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sleep Number Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Invacare Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Nihon Kohden Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. CareFusion
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Becton Dickinson
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Circadia
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Inogen
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Itamar Medical
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. ProTech Sleep Solutions
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦